Flow cytometric DNA index, G-band karyotyping, and comparative genomic hybridization in detection of high hyperdiploidy in childhood acute lymphoblastic leukemia

Journal of Pediatric Hematology/Oncology

Volumn 28, Issue 3, 2006, Pages 134-140

  Nygaard, Ulrikka ^a   Larsen, Jacob ^b   Kristensen, Tim D ^a   Wesenberg, Finn ^e   Jonsson, Olafur G ^f   Carlsen, Niels T ^d   Forestier, Erik ^g   Kirchhoff, Maria ^a   Larsen, Jørgen K ^b   Schmiegelow, Kjeld ^a   Christensen, Ib J ^b,c  

^a Rigshospitalet   (Denmark)

^b FINSEN LABORATORY   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^g UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Childhood acute lymphoblastic leukemia; Comparative genomic hybridization; Flow cytometry DNA index; High hyperdiploidy; Subclone

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOGENETICS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIPLOIDY; DISEASE CLASSIFICATION; DNA DETERMINATION; FEMALE; FLOW CYTOMETRY; HUMAN; HYPERDIPLOIDY; INTERMETHOD COMPARISON; KARYOTYPING; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MOLECULAR CLONING; NUMERICAL CHROMOSOME ABERRATION; PRIORITY JOURNAL; PROGNOSIS;

CHILD; CHROMOSOME ABERRATIONS; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; KARYOTYPING; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; NUCLEIC ACID HYBRIDIZATION; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 33646903314     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/01.mph.0000210064.80828.3e     Document Type: Article

References (26)

1. Pui CH, Crist WM, Look AT. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood. 1990;76:1449-1463.
2. Chessels JM, Swansbury GJ, Reeves B, et al. Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia. Br J Haematol. 1997;99:93-100.
3. Forestier E, Johansson B, Gustafsson G, et al. Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periods. For the Nordic Society of Paediatric Haematology and Oncology (NOPHO) Leukaemia Cytogenetic Study Group. Br J Haematol. 2000;110:147-153.
4. Hann I, Vora A, Harrison G, et al. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. Br J Haematol. 2001;113:103-114.
5. Maloney KW, Shuster JJ, Murphy S, et al. Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986-1994. Leukemia. 2000;14:2276-2285.
6. Pui CH, Boyett JM, Rivera GK, et al. Long-term results of total therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital. Leukemia. 2000;14:2286-2294.
7. Belkov VM, Krynetski EY, Schuetz JD, et al. Reduced folate carrier expression in acute lymphoblastic leukemia: a mechanism for ploidy but not lineage differences in methotrexate accumulation. Blood. 1999;93:1643-1650.
8. Kaspers GJ, Smets LA, Pieters R, et al. Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study. Blood. 1995;85:751-756.
9. Synold TW, Relling MV, Boyett JM, et al. Blast cell methotrexate- polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia. J Clin Invest. 1994;94:1996-2001.
10. Whitehead VM, Vuchich MJ, Lauer SJ, et al. Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (greater than 50 chromosomes) B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group Study. Blood. 1992;80:1316-1323.
11. Ito C, Kumagai M, Manabe A, et al. Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: a distinct biological entity with a marked propensity to undergo apoptosis. Blood. 1999;93:315-320.
12. Kumagai M, Manabe A, Pui CH, et al. Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome. J Clin Invest. 1996;97:755-760.
13. Schultz KR, Pullen J, Sather HN, et al. Biology-driven classification of childhood acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). Blood. 2004;104:151a.
14. Kirchhoff M, Gerdes T, Rose H, et al. Detection of chromosomal gains and losses in comparative genomic hybridization analysis based on standard reference intervals. Cytometry. 1998;31:163-173.
15. Kirchhoff M, Gerdes T, Maahr J, et al. Deletions below 10 megabasepairs are detected in comparative genomic hybridization by standard reference intervals. Gene Chromosomes Cancer. 1999;25:410-413.
16. Forestier E, Holmgren G, Roos G. Flow cytometric DNA index and karyotype in childhood lymphoblastic leukemia. Anal Cell Pathol. 1998;17:145-156.
17. Kristensen TD, Wesenberg F, Jonsson OG, et al. High-resolution comparative genomic hybridisation yields a high detection rate of chromosomal aberrations in childhood acute lymphoblastic leukaemia. Eur J Haematol. 2003;70:363-372.
18. Vindelov LL, Christensen IJ. A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis. Cytometry. 1990;11:753-770.
19. Harrison CJ, Martineau M, Seeker-Walker LM. The Leukaemia Research Fund/United Kingdom Cancer Cytogenetics Group Karyotype Database in acute lymphoblastic leukaemia: a valuable resource for patient management. Br J Haematol. 2001;113:3-10.
20. Heerema NA, Sather HN, Sensel MG, et al. Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes). J Clin Oncol. 2000;18:1876-1887.
21. Pui CH, Raimondi SC, Williams DL. Isochromosome 17q in childhood acute lymphoblastic leukemia: an adverse cytogenetic feature in association with hyperdiploidy? Leukemia. 1988;2:222-225.
22. Jackson JF, Boyett J, Pullen J, et al. Favorable prognosis associated with hyperdiploidy in children with acute lymphocytic leukemia correlates with extra chromosome 6. A Pediatric Oncology Group Study. Cancer. 1990;66:1183-1189.
23. Harris MB, Shuster JJ, Carroll A, et al. Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group Study. Blood. 1992;79:3316-3324.
24. Moorman AV, Richards SM, Martineau M, et al. Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia. Blood. 2003;102:2756-2762.
25. Pui CH, Raimondi SC, Dodge RK, et al. Prognostic importance of structural chromosomal abnormalities in children with hyperdiploid (greater than 50 chromosomes) acute lymphoblastic leukemia. Blood. 1989;73:1963-1967.
26. Raimondi SC, Pui CH, Hancock ML, et al. Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia. Leukemia. 1996;10:213-224.